Package Leaflet: Information for the User
Rixacam 20 mg Hard Capsules EFG
rivaroxaban
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Rixacam contains the active substance rivaroxaban and is used in adults to:
Rixacam is used in children and adolescents under 18 years of age and with a body weight of 50 kg or more to:
Rivaroxaban belongs to a group of medicines called antithrombotic agents. It works by blocking a factor involved in blood clotting (factor Xa) and thus reducing the tendency of blood to form clots.
Do not take Rixacam
Do not take Rixacam and inform your doctorif any of these circumstances apply to you.
Warnings and precautions
Consult your doctor or pharmacist before taking this medicine.
Be particularly careful with this medicine
(bronchiectasis) or have had a previous bleeding in the lungs
Tell your doctor if you have any of these conditionsbefore taking this medicine. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.
If you need to have surgery
Children and adolescents
Rixacam 20 mg capsules are not recommended in children with a body weight below 50 kg. There is not enough information on its use in children and adolescents for adult indications.
Other medicines and Rixacam
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.
If any of these circumstances apply to you, tell your doctorbefore taking this medicine, as the effect of this medicine may be increased. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.
If your doctor considers that you have a higher risk of developing stomach or intestinal ulcers, they may recommend that you also use a treatment to prevent ulcers.
If any of these circumstances apply to you, tell your doctorbefore taking this medicine, as the effect of this medicine may be reduced. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.
Pregnancy and breastfeeding
Do not take this medicine if you are pregnant or breastfeeding. If there is a possibility that you may become pregnant, use a reliable contraceptive while taking this medicine. If you become pregnant while taking this medicine, tell your doctor immediately, who will decide how you should be treated.
Driving and using machines
This medicine may cause dizziness (a common side effect) or fainting (an uncommon side effect) (see section 4, "Possible side effects"). Do not drive, ride a bicycle, or use tools or machines if you are affected by these symptoms.
Rixacam contains lactose monohydrate (a type of sugar) and sodium
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per capsule; this is essentially "sodium-free".
Follow exactly the instructions for taking this medicine as indicated by your doctor. If you are unsure, consult your doctor or pharmacist again.
You must take Rixacam with a meal.
Swallow the capsule preferably with water.
If you have difficulty swallowing the capsule whole, consult your doctor about other ways to take Rixacam. The contents of the capsule can be mixed with water or apple puree immediately before taking it.
This mixture should be followed immediately by food.
If necessary, your doctor may also administer the contents of the Rixacam capsule through a gastric tube.
What dose to take
Adults
The recommended dose is one rivaroxaban 20 mg capsule once a day.
If you have kidney problems, the dose may be reduced to one rivaroxaban 15 mg capsule once a day.
If you need to undergo a procedure to treat blocked blood vessels in your heart (called percutaneous coronary intervention - PCI with stent placement), there is limited evidence to reduce the dose to one rivaroxaban 15 mg capsule once a day (or to one rivaroxaban 10 mg capsule once a day if your kidneys do not work properly) in addition to an antiplatelet medicine like clopidogrel.
The recommended dose is one Rixacam 15 mg capsule twice a day for the first 3 weeks.
For treatment after 3 weeks, the recommended dose is one Rixacam 20 mg capsule once a day.
After at least 6 months of anticoagulant treatment, your doctor may decide to continue treatment with one 10 mg capsule once a day or one 20 mg capsule once a day.
If you have kidney problems and are taking one Rixacam 20 mg capsule once a day, your doctor may decide to reduce the dose of treatment after 3 weeks to one Rixacam 15 mg capsule once a day if the risk of bleeding is greater than the risk of another blood clot.
Children and adolescents
The dose of Rixacam depends on body weight and will be calculated by the doctor.
Take each dose of Rixacam with a drink (e.g. water or juice) during a meal. Take the capsules every day at approximately the same time. Consider setting an alarm to remind you
For parents or caregivers: observe the child to ensure they take the entire dose.
Since the dose of Rixacam is based on body weight, it is important to attend scheduled visits with the doctor, as it may be necessary to adjust the dose as weight changes.
Never adjust the dose of Rixacam on your own. Your doctor will adjust the dose if necessary.
Do not pour out the contents of the capsule to try to obtain a fraction of the dose of the capsule. If a smaller dose is required, please use the alternative presentation that contains rivaroxaban in the form of oral suspension granules.
In children and adolescents who cannot swallow the capsules whole, please use products that contain rivaroxaban in the form of oral suspension granules.
If the oral suspension is not available, you can pour out the contents of the Rixacam capsule and mix it with water or apple puree immediately before taking it. Take some food after taking this mixture. If necessary, your doctor may also administer the contents of the Rixacam capsule through a gastric tube.
If you spit out the dose or vomit
Call your doctor if you spit out the dose or vomit repeatedly after taking this medicine.
When to take Rixacam
Take the capsule every day, until your doctor tells you to stop.
Try to take the capsule at the same time every day, to help you remember.
Your doctor will decide how long you should continue taking the treatment.
To prevent the formation of blood clots in the brain (stroke) or in other blood vessels:
If it is necessary to normalize your heartbeat through a procedure called cardioversion, take this medicine at the times your doctor has indicated.
If you take more Rixacam than you should
Call your doctor immediately if you have taken too many capsules of this medicine. Taking too much Rixacam increases the risk of bleeding.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Rixacam
Adults, children, and adolescents:
If you stop taking Rixacam
Do not stop taking this medicine without talking to your doctor first, as this medicine prevents the development of a serious condition.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Like other similar medicines to reduce blood clot formation, this medicine can cause bleeding, which can endanger the patient's life. Excessive bleeding can cause a sudden drop in blood pressure (shock). In some cases, the bleeding may not be evident.
Tellyour doctor immediately if you or the child suffer from any of the following adverse effects:
Your doctor will decide whether to keep you under closer observation or change your treatment.
The frequency of these adverse effects is very rare (up to 1 in 10,000 people).
The frequencies of severe allergic reactions are very rare (anaphylactic reactions, including anaphylactic shock; may affect up to 1 in 10,000 people) and uncommon (angioedema and allergic edema; may affect up to 1 in 100 people).
General list of possible adverse effects found in adults, children, and adolescents
Frequent(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Very rare(may affect 1 in 10,000 people)
Frequency not known(frequency cannot be estimated from available data)
Adverse effects in children and adolescents
In general, the adverse effects observed in children and adolescents treated with rivaroxaban were similar to those observed in adults and their severity was mainly mild to moderate.
Adverse effects that were more frequently observed in children and adolescents:
Very frequent(may affect more than 1 in 10 people)
Frequent(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the Spanish Medicines Surveillance System for Human Use: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the blister pack and on the packaging after CAD. The expiration date is the last day of the month indicated.
PVC/PVdC/Al blisters: Do not store above 30°C. Store in the original packaging to protect from moisture.
Al/Al blisters: No special storage conditions are required.
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Rixacam
Appearance of the product and package contents
Rixacam hard capsules 20 mg are a white to off-white powder packaged in size "0" (approximately 22 mm long) capsules with opaque brown caps and bodies.
The hard capsules are packaged in PVC/PVdC/Al or Al/Al blisters.
Rixacam 20 mg is available in packages of 14, 28, or 98 hard capsules.
Only some package sizes may be marketed.
Marketing authorization holder
Adamed Laboratorios, S.L.U.
c/ de las Rosas de Aravaca, 31 - 2ª planta
28023 Madrid
Spain
Manufacturer
Adamed Pharma S.A.
ul. marsz J. Pilsudskiego 5, Pabianice, 95-200
Poland
or
Zentiva S.A.
B-dul Theodor Pallady nr. 50, sector 3, Bucharest, 032266 Romania
or
Pharmadox Healthcare Ltd.
KW20A Kordin Industrial Park, Paola, PLA3000, Malta
This medicine is authorizedin the Member States of the European Economic Area under the following names:
Member State | Medicine name |
Poland | RIXACAM |
Czech Republic | RIXACAM |
Spain | Rixacam 20 mg hard capsules EFG |
Date of the last revision of this leaflet: February 2024
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es.
package and additional information